维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Servidei T"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines显示文摘	Morosetti R Servidei T Mirabella M	2004	Int J Oncol2004，25，2：	1
	2	The PPAR gamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines显示文摘	Morosetti R Servidei T Mirabella M	2004	Int J Oncol2004，25，：	1
	3	Chemoresistanttumor cell lines display altered epidermal growth factor re-ceptor and HER3 signaling and enhanced sensitivity to ge-fitinib显示文摘	Servidei T Riccardi A Mozzetti S	2008	Int J Cancer2008，123，12：	1
	4	The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines显示文摘	MOROSETTI R SERVIDEI T MIRABELLA M	2004	Int J Oncal2004，25，：	1
	5	Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma ceils is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation 显示文摘	Servidei T Riccardi A Sanguinetti M	2006	J Cell Physiol2006，208，1：	1
	6	Chemoresistant tumor cell lines display ahered epidennal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib显示文摘	Servidei T Riccardi A Mozzetti S	2008	Int J Cancer2008，123，12：	1
	7	The PPAR gamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines显示文摘	Morosetti R Servidei T Mirabella M	2004	Int J Oncol2004，25，2：	1
	8	Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER- 3 signaling and enhanced sensitivity to gefitinib显示文摘	Servidei T Riccardi A Mozzetti S	2008	Int J Cancer2008，123，12：	1
	9	The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines显示文摘	MOROSETTI R SERVIDEI T MIRABELLA M	2004	Int J Oncol2004，25，2：	1
	10	The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis anddifferentiation of human glioblastoma cell lines显示文摘	Morosetti R Servidei T Mirabella M	2004	Int J Oncol2004，25，：	1
	11	Coordinate regulation of STAT signaling and c-fos expression by the tyrosine phosphatase SHP-2显示文摘	AOKI Y LEWIS SE	1998	J Biol Chem1998，273，：	1
	12	The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines显示文摘	Morosetti R Servidei T Mirabella M	2004	Int J Oncol2004，25，2：	1
	13	The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines 显示文摘	Morosetti R Servidei T Mirabella M	2004	Int J Oncol2004，25，2：	1
	14	The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines 显示文摘	Servidei T Morosetti R Ferlini C	2004	Oncol Res2004，14，78：	1
	15	The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differ- entiation of human glioblastoma cell lines显示文摘	MOROSETTI R SERVIDEI T MIRABELLA M	2004	Int J Oncol2004，25，：	1
	16	Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib显示文摘	Servidei T Riccardi A Mozzetti S	2008	Int J Cancer2008，123，12：	1
	17	Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib 显示文摘	Servidei T Riccardi A Mozzetti S	2008	Int J Cancer2008，123，12：	1
	18	Che- moresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhaneed sensitivity to gefitinib 显示文摘	SERVIDEI T RICCARDI A MOZZETTI S	2008	Int J Cancer2008，123，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费